Related Experiment Videos
Effects of neurodevelopmental therapy on motor performance of infants with Down's syndrome
Insights
This study found that individualized neurodevelopmental therapy did not significantly improve overall development in infants with Down syndrome (DS). However, the therapy did lead to significant gains in achieving specific, individualized treatment goals for these infants.
Area of Science:
- Pediatrics
- Developmental Psychology
- Neurorehabilitation
Background:
- Down syndrome (DS) is a genetic disorder associated with developmental delays.
- Early intervention is crucial for optimizing outcomes in infants with DS.
- Neurodevelopmental therapy aims to improve motor and cognitive function.
Purpose of the Study:
- To evaluate the effectiveness of an individualized home-based neurodevelopmental therapy program for infants with Down syndrome.
- To assess the impact of the therapy on overall developmental progress and specific treatment objective attainment.
Main Methods:
- Twenty infants (2–21 months) with Down syndrome were assessed using the Bayley Scales of Infant Development and Peabody Developmental Motor Scales.
- Infants were randomly assigned to an experimental group (receiving 9 weeks of home-based therapy) or a control group.
- Individualized treatment objectives were established for each infant.
Main Results:
- No significant differences were observed between the experimental and control groups on the Bayley and Peabody Scales post-intervention.
- The experimental group showed statistically significant improvements in achieving their individualized treatment objectives compared to the control group.
Conclusions:
- While not improving overall developmental scores, individualized neurodevelopmental therapy can be effective in targeting specific developmental goals for infants with Down syndrome.
- This suggests a tailored approach may be beneficial for addressing unique needs in this population.
Abstract:
A group of 20 infants with Down's syndrome, aged between two months and 21 months, was tested initially on the Bayley Scales of Infant Development and the Peabody Developmental Motor Scales. Four treatment objectives were developed for each individual infant, and they were then randomly assigned to an experimental or control group. The experimental group were given an individual neurodevelopmental therapy program three times a week in their own homes for a period of nine weeks. When the infants were post-tested on the Bayley and Peabody Scales, no significant difference was found between the two groups. However, there was a statistically significant difference in favour of the experimental group in attainment of individual treatment objectives.